ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026

What happened

ONWARD Medical N.V., a neurotechnology company, said it will release its third-quarter 2026 financial results and host a webcast business update on November 3, 2026, presented by CEO Dave Marver at 2:00 p.m. CET.

Confirmed

Global impact / market context

The update gives investors a scheduled look at revenue, costs and cash use for a company selling its ARC-EX System in the US and Europe. A clear report helps them judge whether sales are funding development of the implantable ARC-IM system.

Analyst inference

ONWARD is a small, loss-making medical device developer, so progress on sales of its cleared ARC-EX System and spending on the investigational ARC-IM implant matter more than broad market moves. Regulatory clearance in the US and Europe supports its commercial push.

Analyst inference

What to watch

1. The webcast on November 3, 2026, at 2:00 p.m. CET, or 8:00 a.m. ET, will include third-quarter 2026 financial results and a comprehensive business update from CEO Dave Marver. Confirmed
2. Listen for any stated sales figures for the ARC-EX System, which is cleared for commercial sale in the US and Europe, and for how quickly the company expects adoption to grow. Proposed
3. Watch cash available, which means money on hand to fund operations, and spending on ARC-IM development, since those show how long ONWARD can fund the investigational implant before needing more money. Analyst inference

Evidence

• globenewswire.com